Related Experiment Videos
Cyclopia-astomia-agnathia-holoprosencephaly association: a case report
Clinical Dysmorphology
|June 20, 2002
Insights
This case study details a rare cyclopia-astomia-agnathia-holoprosencephaly association in a female infant. It explores a potential link between early pregnancy salicylate use and this severe congenital anomaly.
Area of Science:
- Medical Genetics
- Developmental Biology
- Teratology
Background:
- Holoprosencephaly (HPE) is a spectrum of congenital brain malformations.
- The cyclopia-astomia-agnathia-holoprosencephaly association represents a severe form of HPE.
- Understanding the etiology of HPE is crucial for genetic counseling and prevention.
Observation:
- A female infant presented with the severe HPE spectrum, including cyclopia, astomia, and agnathia.
- Detailed clinical and phenotypic data were collected for the affected infant.
- The case highlights the extreme end of HPE malformations.
Findings:
- The study investigates a potential association between maternal salicylate use during early pregnancy and the observed congenital anomalies.
- Salicylates are common medications, and their teratogenic potential in humans is a subject of ongoing research.
- This case provides a specific instance to evaluate the salicylate-teratogenicity hypothesis.
Implications:
- Findings may inform clinical guidelines regarding salicylate use in early pregnancy.
- Further research is warranted to establish or refute a causal link between salicylates and severe HPE.
- This case contributes to the understanding of rare congenital malformation syndromes and their potential environmental triggers.
Abstract:
A female infant is described with cyclopia-astomia-agnathia-holoprosencephaly association. The authors discuss whether the use of salicylates in early pregnancy is implicated.